Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
Background: Loco-regional treatment strategies of colorectal cancer (CRC) metastases are evolving, but biological markers that can benefit patients and assist physicians in clinical decisions are lacking. The primary objective of this systematic review and meta-analysis is to investigate the current...
Main Authors: | Louise B. Callesen, Tana Takacova, Julian Hamfjord, Florian Würschmidt, Karl J. Oldhafer, Roland Brüning, Dirk Arnold, Karen-Lise G. Spindler |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-11-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359221133171 |
Similar Items
-
Time for a lead-time definition? Author response to ‘Why the length of recurrence free survival or “lead-times” can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis’
by: Karen-Lise Garm Spindler, et al.
Published: (2023-03-01) -
Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group
by: Louise Bach Callesen, et al.
Published: (2023-10-01) -
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
by: Christina Glismand Truelsen, et al.
Published: (2022-09-01) -
Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
by: Sven H. Loosen, et al.
Published: (2021-10-01) -
Estimated dose to site of loco-regional recurrence after radiotherapy in anal cancer using point of origin methods
by: Karen Lycke Wind, et al.
Published: (2023-01-01)